Karyopharm Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:KPTI) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 164.42 M127.71 M104.88 M96.23 M108.42 M 負債合計 350.44 M333.6 M343.81 M365.49 M401.34 M 純資産合計 -186.02 M-205.88 M-238.93 M-269.26 M-292.93 M 負債および純資産合計 164.42 M127.71 M104.88 M96.23 M108.42 M 有利子負債合計 94.6 M95.2 M95.82 M96.39 M115.81 M 純負債 -14.11 M25.3 M44.12 M50.49 M52.1 M

ニュース

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm: Putting The Phase 3 Trial In Context (NASDAQ:KPTI)

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slideshow (NASDAQ:KPTI) 2026-03-25

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript

Why Is Karyopharm Therapeutics Stock Trading Lower Today? - Karyopharm Therapeutics (NASDAQ:KPTI)

Rodman & Renshawが Karyopharm株を買い推奨でカバレッジ開始

Rodman & Renshaw initiates Karyopharm stock with buy rating

Cantor Fitzgeraldが試験見通しを理由にKaryopharm株の投資判断を継続

Cantor Fitzgerald reiterates Karyopharm stock rating on trial outlook

Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade